Clinical Trial Update: Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of dexmedetomidine on basal ganglia neuronal activity in Parkinson's disease; current status is not specifie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Dexmedetomidine, Deep Brain Stimulation | Phase 4 | Status: UNKNOWN